Abstract
The purpose of this study was to evaluate the effect of PEGylation on the stabilization of peptide in poly(D,L-lactide-co-glycolide) (PLGA) microspheres for sustained release delivery. As model peptide, growth hormone-releasing peptide-6 (GHRP-6) was conjugated with succinimidyl propionate monomethoxy poly(ethylene glycol) (PEG) with an average molecular weight of 2000 Da. The mono-PEG-GHRP-6 was separated by ion-exchange chromatography, and its molecular mass was identified by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS). The microspheres encapsulating native GHRP-6 or mono-PEG-GHRP-6 were prepared using the single oil-in-water emulsion solvent evaporation method. During incubation in a 0.1 M phosphate buffer (pH 7.4) for one month at 37°C, native GHRP-6 microspheres were identified to form several acylated peptides by reversed-phase HPLC and MALDI-TOF MS, whereas the mono-PEG-GHRP-6 microspheres was not affected from peptide acylation by PLGA. This study demonstrates that PEGylation can stabilize peptide against the acylation reaction occurred in PLGA microspheres.
Similar content being viewed by others
References
Anderson, J. M. and Shive, M. S., Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv. Drug Deliv. Rev., 28, 5–24 (1997).
Bilati, U., Allemann, E., and Doelker, E., Strategic approaches for overcoming peptide and protein instability within biodegradable nano- and microparticles. Eur. J. Pharm. Biopharm., 59, 375–388 (2005).
Camanni, F., Ghigo, E., and Arvat, E., Growth hormone-releasing peptides and their analogs. Front. Neuroendocrinol., 19, 47–72 (1998).
Gombotz, W. R. and Pettit, D. K., Biodegradable polymers for protein and peptide drug delivery. Bioconjug. Chem., 6, 332–351 (1995).
Lucke, A., Kiermaier, J., and Gopferich, A., Peptide acylation by poly(alpha-hydroxy esters). Pharm. Res., 19, 175–181 (2002a).
Lucke, A., Fustella, E., Tessmar, J., Gazzaniga, A., and Göpferich, A., The effect of poly(ethylene glycol)-poly(D,L-lactic acid) diblock copolymers on peptide acylation. J. Control. Release, 80, 157–168 (2002b).
Murty, S. B., Wei, Q., Thanoo, B. C., and DeLuca, P. P., In vivo release kinetics of octreotide acetate from experimental polymeric microsphere formulations using oil/water and oil/oil processes. AAPS PharmSciTech, 5, article 49 (2004).
Murty, S. B., Thanoo, B. C., Wei, Q., and DeLuca, P. P., Impurity formation studies with peptide-loaded polymeric microspheres: Part I. In vivo evaluation. Int. J. Pharm., 297, 50–61 (2005a).
Murty, S. B., Na, D. H., Thanoo, B. C., and DeLuca, P. P., Impurity formation studies with peptide-loaded polymeric microspheres: Part II. In vitro evaluation. Int. J. Pharm., 297, 62–72 (2005b).
Na, D. H., Youn, Y. S., Lee, S. D., Son, M. W., Kim, W. B., DeLuca, P. P., and Lee, K. C., Monitoring of peptide acylation inside degrading PLGA microspheres by capillary electrophoresis and MALDI-TOF mass spectrometry. J. Control. Release, 92, 291–299 (2003a).
Na, D. H., Murty, S. B., Lee, K. C., Thanoo, B. C., and DeLuca, P. P., Preparation and stability of PEGylated octreotide for application to microsphere delivery. AAPS Pharm-SciTech, 4, article 72 (2003b).
Na, D. H., DeLuca, P. P., and Lee, K. C., Direct determination of the peptide content in microspheres by matrixassisted laser desorption/ionization time-of-flight mass spectrometry. Anal. Chem., 76, 2669–2673 (2004).
Na, D. H. and DeLuca, P. P., PEGylation of octreotide: I. Separation of positional isomers and stability against acylation by poly(D,L-lactide-co-glycolide). Pharm. Res., 22, 736–742 (2005).
Na, D. H., Lee, K. C., and DeLuca, P. P., PEGylation of octreotide: II. Effect of N-terminal mono-PEGylation on biological activity and pharmacokinetics. Pharm. Res., 22, 743–749 (2005).
Na, D. H., Lee, J. E., Jang, S. W., and Lee, K. C., Formation of acylated growth hormone-releasing peptide-6 by poly (lactide-co-glycolide) and its biological activity. AAPS PharmSciTech, 8, article 43 (2007).
O’Donnell, P. B. and McGinity, J. W., Preparation of microspheres by the solvent evaporation technique. Adv. Drug Deliv. Rev., 28, 25–42 (1997).
Park, E. J., Na, D. H., and Lee, K. C., In vitro release study of mono-PEGylated growth hormone-releasing peptide-6 from PLGA microspheres. Int. J. Pharm., 343, 281–283 (2007).
Ryu, K. W. and Na, D. H., Stability of octreotide acetate in aqueous solutions and PLGA films. J. Kor. Pharm. Sci., 39, 353–357 (2009).
Sinha, V. R. and Trehan, A., Biodegradable microspheres for parenteral delivery. Crit. Rev. Ther. Drug Carrier Syst., 22, 535–602 (2005).
Yeo, Y. and Park, K., Control of encapsulation efficiency and initial burst in polymeric microparticle systems. Arch. Pharm. Res., 27, 1–12 (2004).
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Park, E.J., Tak, T.H., Na, D.H. et al. Effect of PEGylation on stability of peptide in poly(lactide-co-glycolide) microspheres. Arch. Pharm. Res. 33, 1111–1116 (2010). https://doi.org/10.1007/s12272-010-0718-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12272-010-0718-z